Melissa Hollo: Intravenous Iron Shows Better Results Than Oral Iron in Pregnancy
Melissa Hollo, Director of Project Management at hc1 and Licensed Independent Clinical Social Worker, shared Robert Brown’s post on LinkedIn, adding:
”A well-done study in Obstetrics and Gynecology reinforcing what many of us are seeing in practice:
Intravenous ferumoxytol isn’t just an alternative to oral iron in pregnancy, it’s more effective.
This randomized trial shows:
- Significantly greater increases in hemoglobin with IV ferumoxytol vs oral ferrous sulfate
- Meaningful improvements in ferritin and iron indices
- Better correction of anemia by the time of delivery
For a condition as common, and consequential, as iron deficiency anemia in pregnancy, this matters.
We cannot continue to rely on oral iron alone when:
- Absorption is variable
- Tolerability limits adherence
- Time to correction is often too slow for the peripartum window
This is exactly why earlier identification and more effective treatment pathways are critical.
The takeaway is clear:
If we are serious about improving maternal outcomes, IV iron should be considered sooner, not later.
Learn how we’re supporting earlier maternal risk detection.”
Robert Brown, Academic Obstetrician with extensive clinical experience shared a post on LinkedIn about a recent article by Irogue I Igbinosa, published in Obstetrics and Gynecology։
”IV iron versus oral iron pregnancy anemia.”
Title: Intravenous Ferumoxytol Compared With Oral Ferrous Sulfate for Iron Deficiency Anemia in Pregnancy
A Randomized Controlled Trial
Authors: Irogue I Igbinosa, Stephanie A Leonard, Ijeoma Iwekaogwu, Elizabeth B Sherwin, Caroline Berube, Deirdre J Lyell

Stay updated on all scientific advances with Hemostasis Today.
-
Apr 20, 2026, 14:46Annalisa Paviglianiti: Real-World Outcomes with Maribavir for CMV After Hematopoietic Cell Transplantation
-
Apr 20, 2026, 14:45New Leadership and Expanding Global Impact in Hemophilia – WFH
-
Apr 20, 2026, 14:43Michael Baffuor-Asare: Rethinking How Me Manage Rare Blood Groups
-
Apr 20, 2026, 14:42Noor Ahmed Mirwani: Infectious Mononucleosis Through the Lens of Atypical Lymphocytes
-
Apr 20, 2026, 14:40Irma Rastegayeva: The Evolution of Healthcare Access – From Royal Free Hospital to the Modern NHS
-
Apr 20, 2026, 14:37Brian O Mahony: With Old Friends From The Vietnam Haemophilia Association at WFH Congress 2026
-
Apr 20, 2026, 12:14Yanki Yarman: Linking Genetic Variants to Clinical Outcomes in Thrombosis
-
Apr 20, 2026, 12:09Syed Sibtain Raza: White Blood Cells – Understanding Morphology for Better Diagnosis
-
Apr 20, 2026, 11:23Bastu Odoka: Jehovah’s Witness News on Transfusion… and a Question Worth Asking